#Japan #Kumamoto #Glutathione #Saishunkan #Ginseng Extract

Introduction

Saishunkan Pharmaceutical Co., Ltd., based in Kumamoto Prefecture, has recently made headlines by securing a patent for an innovative approach to skin whitening, leveraging the power of glutathione. The company has developed a skin whitening agent, anti-aging topical solution, a UV damage repair topical product, all utilizing a rare ginseng extract known for its content of ginsenosides Rg3 and Rg5. Unlike mainstream methods focusing on supplementation, Saishunkan is taking a groundbreaking stand against the reduction of glutathione levels, contributing to an exciting shift in the beauty industry.

Four Decades of Expertise in Ginseng

The relationship between Saishunkan and the high-grade Korean ginseng, especially the “Chohakjin” variety native to the Changbai Mountains, dates back nearly 40 years. Over this period, the firm has identified the root fibers of the seven-year-old ginseng, rich in ginsenosides, as a premium material for effective skincare solutions. Utilizing techniques derived from traditional Chinese medicine, Saishunkan has successfully extracted various compounds through four distinct methods: water extraction, oil extraction, fermentation extraction, and steam treatment. The patent filed in 2019 and approved in 2026 signifies a leap in understanding the properties of the ginseng extract.

Uniting Ancient Tradition with Modern Science

Amidst the four patented applications, one prominent advancement is the formulation of an anti-aging topical solution comprising the Korean ginseng extract rich in ginsenosides Rg3 and Rg5, specifically addressing UV damage reduction by increasing glutathione levels within cells. Glutathione is known for its dual role: it not only inhibits the enzyme tyrosinase, which leads to melanin production but also reduces existing melanin into lighter tones. However, glutathione's role in detoxification takes precedence, often limiting its availability for cosmetic purposes. When the skin is exposed to UV light, glutathione can be depleted drastically, decreasing its efficacy as a whitening agent.

The study reveals that cells treated with high-pressure steam processed ginseng extract showed significantly less reduction in glutathione when exposed to UV rays, implying that this extract could potentially conserve glutathione levels that would otherwise be wasted in detoxifying harmful reactive oxygen species.

Efficacy in Melanin Production Regulation

Focusing on the effective suppression of melanin production, the ginseng extract demonstrates an impressive ability to modulate melanin synthesis, indicating that the interplay of different ginsenosides contributes to this effect rather than isolated actions. Specifically, the extract appears to decrease the ginsenosides that promote melanin synthesis while enhancing those that suppress it, revealing new insights into their roles—a significant breakthrough in the understanding of ginsenoside interactions.

Pioneering Thoughts on Glutathione

Notably, these research efforts and patent filings were initiated in 2019, long before glutathione garnered widespread attention for its application in beauty products. Saishunkan’s strategic approach of naming glutathione as an 'intrinsic antioxidant component' rather than a mere supplement signifies a proactive perspective on skincare. By prioritizing the preservation of glutathione levels within the body, this innovative method embodies the company’s Hanpō (traditional Chinese medicine) philosophy—a fundamental approach that underscores the importance of protecting and maintaining our natural resources.

Conclusion

Saishunkan Pharmaceutical’s recent patent embodies a significant advancement in skincare, particularly in the realms of whitening and anti-aging. By blending traditions with modern science, this innovative brand not only promotes skin health but also ensures the sustainable use of essential compounds like glutathione. Through such innovative practices, the company aims to revolutionize how beauty products are designed and perceived, offering a promising future for skincare enthusiasts worldwide. As this patent progresses, it emphasizes that skincare is not just about supplementation but also preserving and effectively utilizing the body’s own resources in combating skin aging and damage.

About Saishunkan Pharmaceutical

Founded in 1932, Saishunkan Pharmaceutical has been a leader in the production and sale of traditional Chinese medicine, such as their renowned products "Pain Relief Decoction" and "Domohorn Wrinkle". The company operates on the principle that humans are a part of nature, utilizing carefully selected raw materials to unlock their potential through advanced pharmaceutical techniques. Their commitment to sustainability and community support initiatives, coupled with a vision for the future, underscores Saishunkan’s role as a steward of both health and the environment.